Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer

Qilu Hospital of Shandong University · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
her2-positive gastric cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 915983
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.